April CFAR Seminar
Sara Gianella Weibel + CFAR Excellence Awards
Wednesday, April 10, 2024
9:35AM - 11:30AM PT
Carr Auditorium, ZSFG - Building 3 and Via Zoom
|
CFAR-wide networking and celebration lunch with Dr. Gianella Weibel and CFAR Excellence Awardees after the seminar in Pride Hall Room 1940/50 from 11:30-1:00p.
|
|
|
| Suppressing Asymptomatic CMV with Letermovir Reshapes Cardiometabolic Proteome in Treated HIV
Sara Gianella Weibel, MD
Associate Professor of Medicine, UC San Diego
|
|
|
Sara Gianella Weibel, MD, graduated from the University of Zurich (Switzerland). After her residency in Internal Medicine in Switzerland, she began her fellowship in the Department of Infectious Disease and Hospital Epidemiology of the University Hospital of Zurich in 2007. She moved to UC San Diego in 2009 to work as a postdoctoral fellow, and she joined the faculty of the Department of Medicine (Division of Infectious Diseases and Global Public Health) in 2013.
Currently she works both at the UC San Diego Antiviral Research Center, and in her laboratory on the UC San Diego campus, where she oversees bench research. She is interested in applying the latest laboratory techniques and rigorous analytical methods to address some of the most pressing problems in infectious diseases. Her research includes investigating HIV persistence in various tissues and anatomical compartments across the human body. She is interested in understanding the transmission dynamics of HIV in the genital tract and its interactions with co-infecting viruses, especially but not limited to Cytomegalovirus. She is committed in contributing to understand sex and gender differences in HIV pathogenesis and persistence. Finally, she is investigating clinical complications related to persistent immune activation.
|
|
|
One-on-One Meetings with Dr. Gianella Weibel
You all may also be interested in meeting with Dr. Gianella Weibel one-on-one. If you’re interested and available that day, please fill out this form by 5PM PT, Wednesday, April 3rd, https://airtable.com/appgKlW8cF6ttt3FU/shrPpaZ1aAFiwNFDk, and CFAR will do our best to set up a meeting for you. Note: There are limited time slots for the 1-1 meetings.
|
| |
Congratulations to the 2024 CFAR Excellence Awardees!
Dr. Gianella Weibel’s seminar will be followed by short talks
by each of the 2024 awardees (until 11:30am)
|
|
|
2024 CFAR Excellence Award for Basic/Translational Research
|
|
|
Expanding TB vaccine Toolkit: The role of Th17 cells in human M. tuberculosis infection
Paul Ogongo, MSc, PhD
Postdoctoral Scholar,
Division of Experimental Medicine,
University of California San Francisco
|
| |
|
Paul grew up in Kenya where he got his bachelor’s and master’s degrees. In 2019 he earned PhD (Medical Microbiology) from the University of KwaZulu-Natal and Africa Health Research Institute, South Africa, with Dr. Alasdair Leslie studying human lung tissue-resident memory T-cells. He demonstrated differential skewing of gamma-delta T-cells in lesions of M. tuberculosis-infected lung and the role of IL17-producing CD4 T-cells in the immune control of human TB. Paul is a Postdoctoral Scholar in the Division of Experimental Medicine, UCSF, and Helen Hay Whitney Foundation Fellow under the mentorship of Prof. Joel Ernst. Paul’s research focuses on the role of human CD4 T cell immune responses to distinct M. tuberculosis antigens in people with latent TB infection to define the role of CD4 T cell immunity in tuberculosis control. The overarching goal is to identify potential new TB vaccines, improve vaccination strategies against TB, and determine correlates of protection. Paul’s contributions have been recognized internationally including the Rising Star by the Gates Foundation, TuBerculosis Vaccine Initiative Young Scientist award, among others. Paul is a co-chair of the Early Career Researchers (ECR) Network of the Working Group of New TB Vaccines which is part of the Stop TB Partnership.
|
2024 CFAR Excellence Award for Clinical Research
|
|
|
The menopausal transition in women with and without HIV
Rebecca Abelman MD
Assistant Professor
Division of Infectious Diseases
San Francisco VA Health Care System
|
| |
|
Dr. Rebecca Abelman is an Assistant Professor at UCSF in the Division of Infectious Diseases at the San Francisco VA Health Care System. Her research is in sex-based differences in aging-associated comorbidities among people living with HIV and the contribution of menopause to comorbidities in women with HIV.
|
|
|
2024 CFAR Excellence Award for Socio-Behavioral Research
|
|
|
Integrating mental health and HIV service delivery for young women
Jennifer Velloza PhD, MPH
Assistant Professor in Residence, Department of Epidemiology and Biostatistics & Division of Prevention Science (joint faculty appointment)
Affiliate Assistant Professor, Department of Global Health, University of Washington
Honorary Associate Faculty, University of the Witwatersrand, Johannesburg, South Africa
|
| |
|
Jennifer Velloza, PhD, MPH is an Assistant Professor in the Department of Epidemiology and Biostatistics at UCSF. She received her MPH in Health Behavior from the University of North Carolina, Chapel Hill, and a PhD in Epidemiology from the University of Washington. Dr. Velloza’s research focuses on advancing the development and delivery of effective bio-behavioral HIV, STI, and mental health interventions for adolescent girls and young women. She has conducted collaborative implementation research in Southern and Eastern Africa since 2011 and her research toolkit includes skills in behavior change theory, mixed methods, human-centered design, and community-based participatory research approaches. Dr. Velloza is also the Associate Program Director for Curriculum for the Implementation Science Training Program and is a faculty member with the Partnerships for Research in Implementation Science for Equity (PRISE) Center at UCSF.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
1700 Owens Street | San Francisco, None 94158 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
| |
|
|
